Novel N-hydroxypropenamide compound and pharmaceutical composition for preventing or… Application KR-20230155311-A Republic of Korea 10 Nov 2023
Novel N-hydroxypropenamide compound and pharmaceutical composition for preventing or… Application KR-20230155310-A Republic of Korea 10 Nov 2023
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1… Grant US-11497756-B2 United States of America 15 Nov 2022
Alvocidib prodrugs and their use as protein kinase inhibitors Grant US-11279694-B2 United States of America 22 Mar 2022
N-HYDROXYCARBOXAMIDE DERIVATIVES USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE… Application WO-2022038116-A1 World Intellectual Property Organisation (WIPO) 24 Feb 2022
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer Grant US-11034710-B2 United States of America 15 Jun 2021
Combination therapies for treatment of cancer Grant US-10835537-B2 United States of America 17 Nov 2020
Combination therapies for treatment of cancer Grant US-10682356-B2 United States of America 16 Jun 2020
Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity Grant US-10654814-B2 United States of America 19 May 2020
Predicting response to alvocidib by mitochondrial profiling Grant US-10624880-B2 United States of America 21 Apr 2020
Combination therapies for treatment of cancer Grant US-10568887-B2 United States of America 25 Feb 2020
Alvocidib prodrugs having increased bioavailability Grant US-10562925-B2 United States of America 18 Feb 2020
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity Grant US-10512634-B2 United States of America 24 Dec 2019
Profiling peptides and methods for sensitivity profiling Grant US-10422788-B2 United States of America 24 Sep 2019
Predicting response to alvocidib by mitochondrial profiling Grant US-10357488-B2 United States of America 23 Jul 2019
Profiling peptides and methods for sensitivity profiling Grant US-10267787-B2 United States of America 23 Apr 2019
Alvocidib prodrugs having increased bioavailability Grant US-10259835-B2 United States of America 16 Apr 2019
Profiling peptides and methods for sensitivity profiling Grant US-10132797-B2 United States of America 20 Nov 2018
Useful as bicyclic hydroxamic acid inhibitors for histone deacetylase activity in mammals Application KR-20180098593-A Republic of Korea 04 Sep 2018
Predicting response to alvocidib by mitochondrial profiling Grant US-9901574-B2 United States of America 27 Feb 2018
PLURIPOTENT STEM CELL-DERIVED 3D RETINAL TISSUE AND USES THEREOF Application WO-2017176810-A1 World Intellectual Property Organisation (WIPO) 12 Oct 2017
Alvocidib prodrugs having increased bioavailability Grant US-9758539-B2 United States of America 12 Sep 2017
BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY Application WO-2017108282-A1 World Intellectual Property Organisation (WIPO) 29 Jun 2017